Circulating Hematopoietic Stem/Progenitor Cells subsets contribute to human hematopoietic homeostasis

Pamela Quaranta,Luca Basso-Ricci,Raisa Jofra Jofra Hernández,Guido Pacini,Matteo Maria Naldini,Matteo Barcella,Luca Seffin,Giulia Pais,Giulio Spinozzi,Fabrizio Benedicenti,Carlo Pietrasanta,Jin-Gyu Cheong,Andrea Ronchi,Lorenza Pugni,Francesca Dionisio,Ilaria Monti,Stefania Giannelli,Silvia Darin,Federico Fraschetta,Graziano Barera,Francesca Ferrua,Valeria Calbi,Marco Ometti,Raffaella Di Micco,Fabio Mosca,Steven Zvi Josefowicz,Eugenio Montini,Andrea Calabria,Maria Ester Bernardo,Maria Pia Cicalese,Bernhard Gentner,Ivan Merelli,Alessandro Aiuti,Serena Scala
DOI: https://doi.org/10.1182/blood.2023022666
IF: 20.3
2024-03-07
Blood
Abstract:Circulating multi-lymphoid progenitors are primed for the seeding of the thymus and contribute to steady-state T cell lymphopoiesis. Circulating HSPC are responsible for clonal redistribution among BM niches and actively participate to human hematopoiesis In physiological conditions, few circulating hematopoietic stem/progenitor cells (cHSPC) are present in the peripheral blood but their contribution to hematopoietic homeostasis in humans remain unsolved. By integrating advanced immunophenotyping, cellular indexing of transcriptomes and epitopes by sequencing (CITE-seq), functional single-cell assays and integration site (IS) clonal tracking, we unveiled the phenotypic composition, the transcriptional features and the biological role of human cHSPC subpopulations in relationship to their bone marrow (BM) counterpart. We found that cHSPC progressively reduced in cell count over aging and are enriched for primitive, lymphoid and erythroid subpopulations, showing pre-activated transcriptional and functional state. Moreover, cHSPC have low expression of multiple BM-retention molecules, but maintain their homing potential after xenotransplantation. By generating a comprehensive Human Organ-Resident HSPC (HuOR) dataset based on scRNAseq data, we detected organ-specific seeding properties of the distinct trafficking HSPC subpopulations. Of note, circulating multi-lymphoid progenitors (MLP) are primed for seeding the thymus and actively contribute to T-cell production at steady state in patients treated with HSPC-gene therapy (GT). Human clonal tracking data from GT patients also showed that cHSPC connect distant BM niches and participate to steady-state hematopoietic production, with primitive cHSPC having the highest re-circulation capability to travel in and out the BM. Finally, in case of hematopoietic impairment, cHSPC composition reflects the BM-HSPC content and might represent a biomarker of the BM state for clinical and research purposes. Overall, our comprehensive work unveiled fundamental insights into the in vivo dynamics of human HSPC trafficking and its role in sustaining hematopoietic homeostasis.
hematology
What problem does this paper attempt to address?